Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 27, 2017

DrugPatentWatch Database Preview

LORAZEPAM Drug Profile

« Back to Dashboard

What is the patent landscape for Lorazepam, and when can generics launch?

Lorazepam is a drug marketed by Hospira, Leading Pharma Llc, Sandoz, Lupin Ltd, Watson Labs, Sagent Agila, Akorn, Amneal Pharms, Am Therap, Halsey, Watson Labs Inc, Warner Chilcott, Usl Pharma, Paddock Llc, Sun Pharm Inds Ltd, Superpharm, Roxane, Intl Medication Sys, Frontida Biopharm, Vintage Pharms, Mylan, Pharm Assoc, Hi-tech Pharma Co, Mutual Pharm, Par Pharm, Bedford, Dava Pharms Inc, West-ward Pharms Int, Ani Pharms Inc, and Bedford Labs. and is included in sixty-eight NDAs.

The generic ingredient in LORAZEPAM is lorazepam. There are eleven drug master file entries for this compound. Fifty-nine suppliers are listed for this compound. Additional details are available on the lorazepam profile page.

Summary for Tradename: LORAZEPAM

Patents:0
Applicants:30
NDAs:68
Suppliers / Packagers: see list55
Bulk Api Vendors: see list27
Clinical Trials: see list51
Patent Applications: see list5,647
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LORAZEPAM at DailyMed

Pharmacology for Tradename: LORAZEPAM

Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira
LORAZEPAM
lorazepam
INJECTABLE;INJECTION074282-001May 27, 1994APRXNoNo► Subscribe► Subscribe
Superpharm
LORAZEPAM
lorazepam
TABLET;ORAL071246-001Feb 9, 1987DISCNNoNo► Subscribe► Subscribe
Usl Pharma
LORAZEPAM
lorazepam
TABLET;ORAL070540-001Dec 22, 1986DISCNNoNo► Subscribe► Subscribe
West-ward Pharms Int
LORAZEPAM
lorazepam
INJECTABLE;INJECTION074496-001Sep 28, 1998DISCNNoNo► Subscribe► Subscribe
Frontida Biopharm
LORAZEPAM
lorazepam
TABLET;ORAL072554-001Mar 29, 1991DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot